期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
抗癌鲜药的生物治疗作用 被引量:8
1
作者 刘玉琴 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第7期418-419,共2页
现代鲜药(金龙胶囊、金水鲜胶囊),是选用鲜活动物、植物药材为原料组方,以现代低温技术,提取其全部有效成分用于恶性肿瘤治疗的中药制剂。创新的制备工艺是我国中药鲜药应用史上的革命。
关键词 现代鲜药 生物治疗作用 多成分免疫调节
下载PDF
Bioactive compounds of sea cucumbers and their therapeutic effects 被引量:10
2
作者 时淑娟 冯文静 +3 位作者 胡松 梁世秀 安妮娜 毛拥军 《Chinese Journal of Oceanology and Limnology》 SCIE CAS CSCD 2016年第3期549-558,共10页
Abstract Sea cucumbers belong to the Class Holothuroidea of marine invertebrates. They are commercially valuable and prized as a food and folk medicine in Asia. Nutritionally, sea cucumbers have an impressive profile ... Abstract Sea cucumbers belong to the Class Holothuroidea of marine invertebrates. They are commercially valuable and prized as a food and folk medicine in Asia. Nutritionally, sea cucumbers have an impressive profile of valuable nutrients such as vitamins, minerals and amino acids. A number of unique biological and pharmacological activities/properties, including anticancer, anticoagulant/antithrombotic, antimicrobial, antioxidant, antihyperlipidemic, antihyperglycemic, anti-inflammatory, antihypertension and radioprotective, have been ascribed to various compounds isolated from sea cucumbers. The therapeutic properties and medicinal benefits of sea cucumbers can be linked to the presence of a wide array ofbioactives, especially triterpene glycosides, acid mucopolysaccharide, sphingoid bases, glycolipids, fucosylated chondroitin sulfate, polysaccharides, phospholipids, cerebrosides, phosphatidylcholines, and other extracts and hydrolysates. This review highlights the valuable bioactive components as well as the multiple therapeutic properties of sea cucumbers with a view to exploring their potential uses as functional foods and a natural source of new multifunctional drugs. 展开更多
关键词 sea cucumber bioactive compounds biological activities pharmacological activities therapeutic effects
下载PDF
Effect of Huangshukuihua(Flos Abelmoschi Manihot) on diabetic nephropathy:a Meta-analysis 被引量:10
3
作者 Sun Qin Yang Gangyi +3 位作者 Zhang Min Zhang Min Chen Shu Chen Pin 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2015年第1期15-20,共6页
OBJECTIVE: To assess the efficacy of Huangshukuihua(Flos Abelmoschi Manihot) on diabetic nephropathy(DN).METHODS: Articles were retrieved from Pub Med,EMBASE, the Cochrane Central Register of Controlled Trials, Web of... OBJECTIVE: To assess the efficacy of Huangshukuihua(Flos Abelmoschi Manihot) on diabetic nephropathy(DN).METHODS: Articles were retrieved from Pub Med,EMBASE, the Cochrane Central Register of Controlled Trials, Web of Science, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure Database, Chinese Evidence-Based Medicine Database, and Wanfang Database. Two reviewers independently reviewed the article. Only randomized controlled trials were included and 27 were identified involving 2239 patients(1143 in the treatment group and 1096 in the control group).RESULTS: Huangshukuihua(Flos Abelmoschi Manihot) had a significant effect on renal function by improving blood urea nitrogen and serum creatinine,reducing urine protein(24-h urine protein, and urinary albumin excretion rate), and improving serum albumin level, compared with the control group.CONCLUSION: Our findings suggest that, although the bioactive ingredients and mechanism underlying renal protection are unknown, the role of Huangshukuihua(Flos Abelmoschi Manihot) in the treatment of DN deserves further investigation. 展开更多
关键词 Diabetic nephropathy Renal insuffi-ciency Flos Abelmoschi Manihot META-ANALYSIS
原文传递
西妥昔单抗联合伊立替康化疗并发大面积脓疱疹1例的护理 被引量:1
4
作者 罗婉 叶祝君 +1 位作者 张德云 许伟芬 《中国误诊学杂志》 CAS 2011年第31期7810-7810,共1页
我科于2011-01-11收治1例胃印戒细胞癌(Borrmann’s四型)并腹腔、结直肠多发转移患者,西妥昔单抗联合伊立替康治疗后出现大面积脓疱疹,经过局部换药、加强抗感染治疗等综合处理,皮疹渐消失。现将护理体会简要报道如下。
关键词 抗体 单克隆/治疗应用/副作用 喜树碱/类似物和衍生物/治疗应用/副作用 药物疗法 联合 脓疱病/化学诱导/护理
原文传递
长春瑞滨化疗59例不良反应的预防护理 被引量:2
5
作者 楚红枝 侯睿 《中国误诊学杂志》 CAS 2012年第8期1991-1991,共1页
长春瑞滨(NVB)是一种半合成的长春碱类抗癌药,通过抑制微管系并与微管蛋白结合,将肿瘤细胞阻断于G2期,使肿瘤细胞死亡。其抗瘤谱广,对非小细胞肺癌、乳腺癌和卵巢癌有较好疗效。但NVB具有很强的刺激性和较大的毒性,静脉给药容易发生... 长春瑞滨(NVB)是一种半合成的长春碱类抗癌药,通过抑制微管系并与微管蛋白结合,将肿瘤细胞阻断于G2期,使肿瘤细胞死亡。其抗瘤谱广,对非小细胞肺癌、乳腺癌和卵巢癌有较好疗效。但NVB具有很强的刺激性和较大的毒性,静脉给药容易发生静脉炎,甚至功能障碍。有文献报道外周静脉给药法致静脉炎的发生率为57.6%~87%[1]。NVB局部刺激症状重,化疗渗漏发生率高。 展开更多
关键词 长春碱/类似物和衍生物/治疗应用/副作用
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部